Key points

  • Necrotizing enterocolitis (NEC) results in an intra-abdominal infection, and treatment includes antimicrobial therapy, bowel rest, parenteral nutrition, and surgery, if clinically or radiologically indicated.

  • In the absence of evidence-based guidelines, many antibiotic combinations are used for NEC treatment in the current practice.

  • Ampicillin and gentamicin are probably adequate for the treatment of stage I or IIA NEC.

  • For proven stage IIB or III NEC, antimicrobial treatment may include anaerobic coverage.

Necrotizing enterocolitis (NEC) is a common and devastating disease in infants with an incidence of approximately 1 per 1000 live births. Prematurity is an important risk factor with up to 9% of preterm infants ≤28 weeks’ gestational age affected. Despite treatment, mortality remains high following NEC. Surviving infants face complications such as failure to thrive, gastrointestinal problems including strictures and adhesions, cholestasis, short bowel syndrome with or without intestinal failure, and neurodevelopmental impairment. Spontaneous intestinal bowel perforation, sometimes confused with NEC, is a different clinical entity occurring in the first week of life in preterm infants , and is not discussed in this chapter. The etiology of NEC is multifactorial, and its treatment includes bowel rest, antibiotics, parenteral nutrition, and, in specific situations, surgery. In this chapter, we discuss the different options for antimicrobial therapy of NEC.

Pathogenesis of NEC

Current evidence suggests that tissue injury results from intestinal inflammation caused by disruption of the gut microbiome and an altered immune response. Preterm infants are especially at high risk of dysbiosis given their exposure to antibiotics and their prolonged hospitalization. , , Prolonged antibiotic exposure in uninfected preterm infants has been associated with an increased risk of NEC. NEC ultimately results in bacterial overgrowth, mimicking a complicated intra-abdominal infection characterized by bowel inflammation with mucosal edema, ulcerations, hemorrhages and coagulation necrosis, localized or diffused peritonitis, and, in some cases, sepsis and bowel perforation.

Clinical presentation and diagnosis of NEC

Age of onset is typically inversely proportional to gestational age. Although relatively rare, term and near-term infants usually develop NEC in the first week of life and very preterm infants after the third week of life. , NEC presents with both digestive and systemic manifestations. Infants generally have abdominal distention and/or tenderness, feeding intolerance, and occult or grossly bloody stools. Nonspecific systemic symptoms include apnea and bradycardia, lethargy, poor perfusion, and respiratory distress. Disease can be mild with only feeding intolerance or sudden and fulminant with multiple organ failure.

Laboratory studies supporting the diagnosis of NEC include abnormal complete blood count with neutropenia or thrombocytopenia, hyponatremia, high C-reactive protein, and metabolic acidosis. Radiological studies are used to confirm the diagnosis of NEC and determine the stage of disease severity according to Bell’s criteria ( Table 12.1 ). Plain abdominal radiography may reveal distended, fixed bowel loops, air fluid levels, pneumatosis intestinalis (intramural gas), portal venous gas, or pneumoperitoneum in the case of intestinal perforation. In recent years, data have accumulated regarding the potential benefits of using abdominal ultrasound in the diagnosis and management of NEC.

TABLE 12.1
Modified Bell Staging for Nec
Bell’s Stages Abdominal Signs and Symptoms Systemic Signs and Symptoms Radiological Features Treatment
Stage I, Suspected NEC
IA Feeding intolerance, mild abdominal distention, occult blood in stools Mild systemic symptoms (apnea and bradycardia, temperature instability) Nonspecific, normal or signs of ileus, mild intestinal dilatation Close clinical observation
NPO
Consider antibiotics without anaerobic coverage
IB Stage IA plus grossly bloody stools
Stage II, Proven NEC
IIA, mild Prominent abdominal distension, abdominal tenderness and wall edema, grossly bloody stools Mild systemic symptoms (as stage I)
Moderate systemic symptoms (stage I plus thrombocytopenia, metabolic acidosis)
Intestinal dilatation, pneumatosis intestinalis, portal venous gas Close clinical, laboratory and radiological observation
NPO, gastric decompression, intravenous fluids and antibiotics with or without anaerobic coverage
IIB, moderate
Stage III, Advanced NEC
IIIA As for stage II plus signs of peritonitis Severe systemic symptoms (stage II plus need for mechanical ventilation, hypotension and shock, severe metabolic and respiratory acidosis, disseminated intravascular coagulation) Stage II plus fixed bowel loops, severe ascites Same as stage II, including anaerobic coverage
Consider surgical intervention
IIIB Stage IIIB plus pneumoperitoneum Same as stage III plus exploratory laparotomy and resection of necrotic bowel or peritoneal drainage
NPO , nil per os (nothing by mouth). Adapted from Walsh and Kliegman and Hall et al.

Although many pathogens have been associated with NEC, no specific microorganism has consistently been linked to this condition. Blood culture is positive in 7% to 30% of cases, and ≤1% of infants with NEC present with an associated meningitis. More rarely, Candida spp. and viruses (e.g., cytomegalovirus, rotavirus, and norovirus) have also been associated with NEC. For most infants with NEC, however, no microorganism is identified, and a polymicrobial infection with endogenous intestinal flora may be assumed. Therefore, antibiotic empirical therapy should be active against enteric Gram-negative aerobic and facultative anaerobic bacilli such as Enterobacteriaceae (e.g., Escherichia coli , Klebsiella spp.); enteric Gram-positive streptococci (e.g., Streptococcus anginosus ); and, in some situations, obligate anaerobic bacilli (e.g., Clostridium perfringens , Bacteroides fragilis ). C. perfringens seems to be associated with more severe and fulminant NEC presentations. However, it is still unclear whether, in general, anaerobic bacteria play a pathogenic or a protective role in the pathogenesis of NEC. Disruption of the intestinal mucosa with subsequent intramural invasion by anaerobic bacteria causes pneumatosis intestinalis . But, anaerobic bacteria are also known to produce short-chain fatty acids po tentially regulating the intestinal inflammatory response. Moreover, Gram-negative rods, as opposed to anaerobic bacteria, are predominant in stools of very-low-birth-weight (VLBW) infants (birth weight <1500 g) who have developed NEC compared to those who have not.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here